Celularity Inc

Pharmaceutical Preparations

CELU Pharmaceuticals & Biotechnology People in Pharmaceuticals & Biotechnology SEC CIK 0001752828 ↗

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Market capitalisation
$40.81M
28,945,961 shares Covers every share class this company has on file.
Insiders on file
3
people who have filed Form 3, 4 or 5 naming this issuer
Value of insider-held stock
$5.41M
from the holdings reported on Forms 3/4/5; this figure has no separate as-of date on file
Insider-held share of market cap
13.26%
insider-held value divided by market capitalisation

What Celularity Inc reports

Revenue and net income below are for fiscal period FY2025, the period label carried by this company’s own annual XBRL filings to the SEC. Fiscal years do not line up between companies — one company’s FY2026 can cover much the same months as another’s FY2025 — so compare the periods, not just the numbers.

Revenue
$26.55M
FY2025 annual revenue, from this company’s own annual XBRL filings to the SEC
Net income
-$91.72M
FY2025 a loss for the period, from this company’s own annual XBRL filings to the SEC
Employees
115
Yahoo Finance
Where the employee count comes from

Headcount comes from Yahoo Finance, not from a filing. The date beside it is the day we retrieved the figure — it is not the date the company counted its staff, and Yahoo does not publish that date. Unlike the SEC filings behind the other figures on this page, this one carries no open licence, so we publish the number and nothing else from that source.

Insiders at Celularity Inc

Shares is what each person last reported holding here.

Everyone below has filed at least one insider report against this company.

Value is that share count priced at the same closing price used everywhere else on this site. A row priced from only some of a person’s securities says so — we do not quietly present a partial sum as a complete one.

Rows are grouped by the role each person reports.

The role comes from the relationship boxes a person ticks on their own insider filings — officer, director, ten per cent owner — not from anything we infer. Somebody who is both an officer and a director appears once, in the combined group, so the row count still matches the figure at the top of this page. Where no filing states a role we say so instead of guessing one.

People who file insider reports against Celularity Inc.
Insider Reported role Shares Value Last action
Officers who also sit on the board 1
Robert J Hariri CEO 2,851,454 $4.79M F Shares withheld for taxes Apr 13, 2026 position reported
Directors 2
Dean C Kehler Dean C Kehler Board Member 303,482 $509.8K A Grant or award Dec 19, 2024 position reported
Richard J. Berman Board Member 67,416 $113.3K A Grant or award Dec 19, 2024 position reported

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

Celularity Inc (CELU) filed a Form 8-K under Item 5.02 (directors and officers) on Aug 7, 2026

Director or officer change filing

The company filed a current report that includes Item 5.02, the item used to report departures, elections or appointments of directors and certain officers, and related pay arrangements. We record only that this filing exists: we have not extracted who left, who joined or whose role changed. Open the filing to read it.

Form 8-K filed Aug 7, 2026, item 5.02. SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Recent insider transactions

Of the 7 rows we hold, 0 are open-market purchases and 0 open-market sales.

The rest — awards, shares withheld to pay tax, option exercises, gifts and so on — follow from an employment contract or a transfer arranged off-market, not from a decision to buy or sell, so counting them would turn this into a pay table.

A price of 0.00 is a real reported figure on gifts (G) and share awards (A) — not a gap in our data.

Insider transactions disclosed to the SEC for Celularity Inc, newest first, each with the filing behind it.
Date Insider Transaction Shares Price Value Filing
Apr 13, 2026 Robert J Hariri F Shares withheld for taxes 1,182 $1.28 $1.5K SEC filing ↗
Apr 13, 2026 Robert J Hariri M Option exercise or conversion 3,281 $0.00 $0 SEC filing ↗
Apr 13, 2025 Robert J Hariri M Option exercise or conversion 3,281 $0.00 $0 SEC filing ↗
Apr 13, 2025 Robert J Hariri F Shares withheld for taxes 1,154 $1.64 $1.9K SEC filing ↗
Dec 19, 2024 Dean C Kehler A Grant or award 67,416 $0.00 $0 SEC filing ↗
Dec 19, 2024 Richard J. Berman A Grant or award 67,416 $0.00 $0 SEC filing ↗
Apr 13, 2024 Robert J Hariri F Shares withheld for taxes 1,154 $4.11 $4.7K SEC filing ↗

From SEC Form 4 filings. Every row links to the filing it came from. How we calculate this.

What a Form 4 is

The report an officer, director or large shareholder must file after trading their own company’s stock.

Corporate ownership links — 2 filers hold a position

Who owns Celularity Inc

Each row is one filer naming this company.

Funds, trusts and other companies file the same ownership forms that executives do. Everything below is taken from those filings, with the position exactly as the filing states it.

Do not add these figures together. 1 of the positions below was reported on a filing shared by several filers at once.

Why the same shares appear twice

On a joint filing every named filer is listed against the whole position, so the same block of stock appears under each name. Those rows are marked joint.

Filers holding a position in Celularity Inc

Funds, trusts and companies that disclose an ownership position in Celularity Inc.
Owner Reported role Shares Filed
Dragasac Ltd TenPercentOwner 6,338,161 joint
Resorts World Inc Pte. Ltd. TenPercentOwner —

See the full ownership map — every entity that files as an owner of a US public company.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Sources and technical notes

Every figure on this page comes from filings to the U.S. SEC via EDGAR. Nothing here is estimated, and nothing is taken from press coverage or company websites.

Share count: cover page of the latest filing (dei:EntityCommonStockSharesOutstanding), taken from Celularity Inc’s own filings and multiplied by our closing price. Full method.

What that share count means

the share count the company itself prints on the cover of its most recent filing, as of the date it signed that filing.

We do not take a market cap from a data vendor, and we do not estimate one: the figure is a share count from Celularity Inc’s own SEC filings multiplied by the closing price we hold for the same stock.